Clinical trial · Interventional
A Pilot Study of Remote Monitoring to Improve Health Related Quality of Life of Men Following Prostate Cancer Treatment.
NCT03434535CI-TRIAL-00042241completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to determine the feasibility of using digital technology and remote monitoring to track health-related measures in men following prostate cancer treatment. Half of the participants will receive tools to monitor their activity and weight, as well as personalized feedback on these measures, while the other half will receive standard of care. Health related quality of life measure will be collected from both groups.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Health-Related Quality Of Life | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Technology Intervention | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Intervention
- description
- The participants will complete a digital health-related quality of life survey on a programmed tablet at baseline and each month for the following 3-6 months. They will also receive an activity sensor and weight scale. Health state data from this group will be generated over a 3-6 month period and remotely monitored. These data will be used to provide personalized feedback regarding the participant's progress towards established goals.
- interventionNames
- Device: Technology Intervention
- type
- NO_INTERVENTION
- label
- Control
- description
- The participants will complete a digital health-related quality of life survey on a programmed tablet at baseline and each month for the following 3-6 months.
Primary outcomes (4)
- measure
- Health-Related Quality of Life
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Male
Show eligibility criteria text
Inclusion Criteria: * Participants must have localized prostate cancer. * Participants must have received treatment at Johns Hopkins * Participants must be classified as overweight (body mass index ≥ 25). * Participants must have wi-fi in their homes. Exclusion Criteria: * Anyone who is unable to give informed consent will be excluded * Anyone who is physically unable to participate in physical activity will be excluded.
References
Publications (0)
Data not yet available
No reference posted for this study.